Ann: Peer Reviewed Journal Publication, page-33

Yes i’m Hoping there is a joint effort on the horizon. When I read the article about Soucek’s latest breakthroughs it reads like PYC peptides (nucleus of cells, undruggable, recent mouse models etc). Surely Soucek hasn’t replicated the PYC technology - that would be very concerning from our point of view. Most likely there is a behind the scenes collaboration happening. Much like the Bioexec view some time ago - give the drug development companies a peptide to play with and see what happens. Just conjecture and I will be interested to hear from our CEO regarding the actual state of play.

I support the short term focus on the platform and delivering some early wins, but I would love to see some focus also on the cancer programme. This attracts a lot of interest. If indeed it is PYC peptides that Soucek is referring to then this would be very welcome news to the market. An international award for cancer research on the back of our technology!!